Assistant Professor of Medicine, Northwestern University
BIOGRAPHY
SEP 18, 2018 8:00 AM PDT
Share
High-throughput CRISPR-Cas9 Genome Engineering in Primary T Cells
Speaker
Abstract
DATE: September 18, 2018
TIME: 08:00am PDT, 11:00am EDT
CRISPR-Cas9 gene editing strategies have revolutionized our ability to engineer the genomes of diverse cell types and species for the robust functional interrogation of complex biological processes. Gene editing in primary T-cells represents an important research tool for the development of T-cell based immunotherapies, the study of the autoimmunity, the understanding of host-pathogen dynamics that drive HIV replication and latency, and creation of chimeric antigen receptor (CAR) T cells for the treatment of various cancers. While these cells have proven resistant to traditional transfection and transduction approaches for the CRISPR-Cas9 gene editing, recent advancements in ribonucleoprotein (RNP) delivery have allowed for efficient primary T-cell editing for the first time. In this webinar, we will present a workflow for the design and delivery of CRISPR-Cas9 RNPs to primary, human T-cells by electroporation. This platform supports the high-throughput, arrayed generation of hundreds of specific gene manipulations in only a few hours time without the use of recombinant DNA or lentiviruses and without the need for selection markers. This approach is widely adaptable to an array of downstream applications and protocols for the study of diverse T-cell processes.
In this webinar, you will learn:
-
Optimal conditions for CRISPR-Cas9 gene editing in primary T cells using RNPs
-
Rules for designing, synthesizing, and validating efficient guide RNAs
-
Considerations for high-throughput functional screening
-
How this approach is being employed to better understand HIV replication and pathogenesis
You May Also Like
SEP 14, 2021
7:00 AM PDT
C.E. CREDITS
SEP 14, 2021
7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
JUN 09, 2021
7:00 AM PDT
C.E. CREDITS
JUN 09, 2021
7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
JUL 15, 2021
9:00 AM PDT
JUL 15, 2021
9:00 AM PDT
Date: July 15, 2021 Time: 9:00am (PDT), 12:00pm (EDT) The Pisces workflow robust, easy-to-use, end-to-end multi-omics solution for highly multiplexed targeted Spatial RNA analysis. VeranomeB...
JUN 03, 2021
12:00 PM CST
JUN 03, 2021
12:00 PM CST
DATE: June 3, 2021 TIME: 12:00pm SGT This webinar is a virtual event that focuses on utilizing the Gibco CTS Rotea System for Cell and Gene Therapy...
NOV 09, 2021
11:00 AM PST
C.E. CREDITS
NOV 09, 2021
11:00 AM PST
Date: November 09, 2021 Time: 11:00am (PDT), 02:00pm (EDT) Clinical translation of human pluripotent stem cells (hPSCs) requires advanced strategies that ensure safe and robust long-term gro...
NOV 17, 2021
8:00 AM PST
C.E. CREDITS
NOV 17, 2021
8:00 AM PST
Date: November 17, 2021 Time: 8:00am (PDT), 11:00am (EDT) From waste disposal to promising biomarkers and therapeutic agents, exosomes and other extracellular vesicles are valuable in resear...
Loading Comments...
Finish Registering
-
DEC 08, 2021Sony Biotechnology Virtual Summit 2021 -
DEC 08, 2021Sample to Answer Clinical Series
-
JAN 25, 2022Lab Compliance Connect
-
FEB 23, 2022Drug Discovery & Development 2022
- See More
-
NOV 28, 2021
-
NOV 28, 2021
- See More
